• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
CHEN Xiuting,WEI Yueyin,QIN Tiantian,WU Chaoquan,LI Yuqing.Analysis of the mechanism of Blumea riparia extract promoting uterine contractionvia in DUB rats[J].Journal Of Pharmaceutical Research,2024,43(1):1-5,14[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2899times   Download 2709次 QR Code for this article
Scan with your phone!
滇桂艾纳香提取物促进DUB大鼠子宫收缩机制分析
陈秀婷1,韦玥吟1,覃田田1,吴超权2,李宇清3
Font:Larger+|Default|Smaller-
(1.广西中医药大学药学院,广西 南宁 530200;2.广西壮族自治区食品药品检验所,广西 南宁 530200;3.广西中医药大学,广西高校中药药理重点实验室,广西 南宁 530200)
摘要:
目的 探讨滇桂艾纳香提取物通过促进子宫平滑肌收缩治疗功能失调性子宫出血(DUB)的作用机制。方法 利用米非司酮联合米索前列醇建立DUB大鼠模型,成模的雌性大鼠40只,随机分5组:正常妊娠组、DUB模型组、益母草颗粒3.125 g•kg-1组、滇桂艾纳香提取物0.4 g•kg-1组以及0.2 g•kg-1组,另取8只未受孕性成熟雌性大鼠作空白对照组,观察滇桂艾纳香提取物对DUB模型大鼠子宫平滑肌收缩的影响,Western Blot法测定大鼠子宫平滑肌中β2肾上腺素受体(β2AR)、环磷腺苷效应元件结合蛋白(CREB)及p-CREB蛋白表达水平,并检测大鼠子宫平滑肌中蛋白激酶A(PKA)活性和Ca2+离子浓度。结果 与DUB模型组相比,滇桂艾纳香提取物显著提高大鼠子宫收缩频率(P<0.05),增加子宫平滑肌Ca2+离子浓度,并且增加p-CREB/CREB蛋白表达(P<0.05);滇桂艾纳香提取物还显著降低了子宫平滑肌PKA活力(P<0.05),但对β2受体表达没有显著影响。结论 滇桂艾纳香提取物可能是通过抑制β2受体的活化,间接增强转录调节因子CREB对与子宫平滑肌收缩相关的转录调控,从而促使子宫肌层收缩,产生治疗DUB的作用。
关键词:  滇桂艾纳香  子宫收缩  功能失调性子宫出血  β2肾上腺素受体
DOI:10.13506/j.cnki.jpr.2024.01.001
基金项目:国家自然科学基金资助项目(No.81960728);中药学广西一流学科项目(No.桂教科研〔2022〕1号);南宁市本级科学研究与技术开发计划项目(No.20193122);广西中医药大学青年创新研究团队项目(No.2015QT002);广西中医药大学一流学科开放课题项目(No.2019XK084)
Publication Date:January 25, 2024
Analysis of the mechanism of Blumea riparia extract promoting uterine contractionvia in DUB rats
CHEN Xiuting1,WEI Yueyin1,QIN Tiantian1,WU Chaoquan2,LI Yuqing3
(1.College of Pharmacy,Guangxi University of Chinese Medicine, Nanning 530000,China; 2.Guangxi Institute For Food and Drug Control, Nanning 530000,China; 3. Key Laboratory of Traditional Chinese Medicine Pharmacology of Education Department of Guangxi Zhuang Autonomous Region,Guangxi University of Chinese Medicine , Nanning 530000,China)
Abstract:
Objective To explore the therapeutic mechanism involved in uterine contraction promoting of Dian-gui Ai-na-xiang extract in dysfunctional uterine bleeding (DUB).Methods A total of 40 mature female rats were successfully modeled and randomly assigned into five groups: the normal pregnancy group, DUB model group, motherwort granule 3.125 g•kg-1 group, Dian-gui Ai-na-xiang extract 0.4 g•kg-1 group, and 0.2 g•kg-1 group. Additionally, eight non-pregnant mature female rats were selected as a blank control group. Deficitone combined with Misocol were used to induce DUB in rats, and the effect of Dian-gui Ai-na-xiang extract on uterine contraction was evaluated. β2 adrenergic receptor, CREB and p-CREB proteins levels in the uterus smooth muscle were determined by western blotting, furthermore. PKA kinase activity and Ca2+ concentration in uterine smooth muscle were detected.Results Compared with the DUB model group, the uterine contraction frequency was increased significantly by the treatment of Dian-gui Ai-na-xiang extract (P<0.05), and uterine Ca2+ concentration in smooth muscle as well as p-CREB/CREB protein expression were increased (P<0.05). Uterine PKA activity was reduced significantly after treating with Dian-gui Ai-na-xiang extract (P<0.05), while no significant changes in β2 receptor protein was observed.Conclusion Dian-gui Ai-na-xiang extract activated transcriptional regulation of CREB indirectly by inhibiting the activation of uterine β2 receptors. This may serve as one of the uterine contraction promoting mechanisms of Dian-gui Ai-na-xiang in DUB rats.
Key words:  Blumea riparia  Uterine contraction  Dysfunctional uterine bleeding  β2-adrenergic receptor
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.